First Bank & Trust Castle Biosciences Inc Transaction History

First Bank & Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$16.0 - $45.99 $59,328 - $170,530	3,708 Added 90.22%	7,818 $172,000
Q1 2022 Apr 29, 2022	BUY	$33.17 - $46.98 $24,313 - $34,436	733 Added 21.71%	4,110 $184,000
Q4 2021 Feb 01, 2022	BUY	$39.06 - $67.58 $91,556 - $158,407	2,344 Added 226.91%	3,377 $145,000
Q3 2021 Oct 18, 2021	BUY	$60.13 - $77.6 $36,619 - $47,258	609 Added 143.63%	1,033 $69,000
Q2 2021 Aug 10, 2021	BUY	$50.07 - $76.78 $21,229 - $32,554	424 New	424 $31,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $458M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on First Bank & Trust with notifications on news.